Duration of Influenza A Virus Shedding in Hospitalized Patients and Implications for Infection Control
- 1 September 2007
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 28 (9) , 1071-1076
- https://doi.org/10.1086/520101
Abstract
Objective.To assess the duration of shedding of influenza A virus detected by polymerase chain reaction (PCR) and cell culture among patients hospitalized with influenza A virus infection.Setting.Mayo Clinic (Rochester, Minnesota) hospitals that cater to both the community and referral populations.Methods.Patients 18 years old and older who were hospitalized between December 1, 2004, and March 15, 2005, with a laboratory-confirmed (ie, PCR-based) diagnosis of influenza A virus infection were consecutively enrolled. Additional throat swab specimens were collected at 2, 3, 5, and 7 days after the initial specimen (if the patient was still hospitalized). All specimens were tested by PCR and culture (both conventional tube culture and shell vial assay). Information on demographic characteristics, date of symptom onset, comorbidities, immunosuppression, influenza vaccination status, and receipt of antiviral treatment was obtained by interview and medical record review. Patients were excluded if informed consent could not be obtained or if the date of symptom onset could not be ascertained.Results.Of 149 patients hospitalized with influenza A virus infection, 50 patients were enrolled in the study. Most patients were older (median age, 76 years), and almost all (96%) had underlying chronic medical conditions. Of 41 patients included in the final analysis, influenza A virus was detected in 22 (54%) by PCR and in 12 (29%) by culture methods at or beyond 7 days after symptom onset. All 12 patients identified by culture also had PCR results positive for influenza A virus.Conclusion.Hospitalized patients with influenza A virus infection can shed detectable virus beyond the 5- to 7-day period traditionally considered the duration of infectivity. Additional research is needed to assess whether prolonging the duration of patient isolation is warranted to prevent nosocomial outbreaks during the influenza season.Keywords
This publication has 17 references indexed in Scilit:
- Antibody response to influenza vaccination in the elderly: A quantitative reviewVaccine, 2006
- Explaining Trends in Hospitalizations for Pneumonia and Influenza in the ElderlyMedical Care Research and Review, 2005
- Duration of Virus Shedding After Trivalent Intranasal Live Attenuated Influenza Vaccination in AdultsInfection Control & Hospital Epidemiology, 2005
- Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral TherapyClinical Infectious Diseases, 2004
- Comparison of SmartCycler Real-Time Reverse Transcription-PCR Assay in a Public Health Laboratory with Direct Immunofluorescence and Cell Culture Assays in a Medical Center for Detection of Influenza A VirusJournal of Clinical Microbiology, 2003
- Comparison of the Directigen Flu A+B Test, the QuickVue Influenza Test, and Clinical Case Definition to Viral Culture and Reverse Transcription-PCR for Rapid Diagnosis of Influenza Virus InfectionJournal of Clinical Microbiology, 2003
- Prolonged Excretion of Amantadine-Resistant Influenza A Virus Quasi Species after Cessation of Antiviral Therapy in an Immunocompromised PatientClinical Infectious Diseases, 2002
- Common Emergence of Amantadine‐ and Rimantadine‐Resistant Influenza A Viruses in Symptomatic Immunocompromised AdultsClinical Infectious Diseases, 1998
- Prolonged Shedding of Amantadine-Resistant Influenza A Viruses by Immunodeficient Patients: Detection by Polymerase Chain Reaction-Restriction AnalysisThe Journal of Infectious Diseases, 1995
- Patterns of Shedding of Myxoviruses and Paramyxoviruses in ChildrenThe Journal of Infectious Diseases, 1981